Nexien BioPharma, Inc. filed its 10-K on Oct 12, 2021 for the period ending Jun 30, 2021. In this report its auditor, M & K CPAS, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0163 USD | -28.04% | 0.00% | -37.07% |
1st Jan change | Capi. | |
---|---|---|
-37.07% | 1.1M | |
+29.98% | 682B | |
+32.39% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.50% | 240B | |
+9.56% | 209B | |
-9.04% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- NXEN Stock
- News Nexien BioPharma, Inc.
- Nexien BioPharma, Inc. Auditor Raises 'Going Concern' Doubt